Amundi Asset Management US’s NPS PHARMACEUTICALS INC NPSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-524,878
Closed -$18.8M 654
2014
Q4
$18.8M Buy
524,878
+105,907
+25% +$3.16M 0.07% 273
2014
Q3
$10.9M Buy
418,971
+165,074
+65% +$4.74M 0.04% 328
2014
Q2
$8.39M Sell
253,897
-20,359
-7% -$588K 0.03% 380
2014
Q1
$8.21M Sell
274,256
-94,958
-26% -$3.27M 0.03% 376
2013
Q4
$11.2M Sell
369,214
-79,597
-18% -$2.19M 0.04% 315
2013
Q3
$14.3M Sell
448,811
-209,507
-32% -$4.81M 0.06% 291
2013
Q2
$9.94M Buy
+658,318
New +$9.12M 0.04% 329

Other funds holding NPSP

Amundi Asset Management US's NPSP Position: Q1 2015 in Review

Amundi Asset Management US sold out of NPS PHARMACEUTICALS INC (NPSP) in Q1 2015, closing a stake of 524,878 shares — an estimated $18.8M sold.

Amundi Asset Management US first reported a position in NPSP in Q2 2013 and held it in 7 quarters. The position peaked at $18.8M in Q4 2014. 1 fund tracked by Wall St. Rank holds NPSP as of Q1 2015.

  • Amundi Asset Management US reported no remaining NPS PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Amundi Asset Management US sold 524,878 NPS PHARMACEUTICALS INC shares in Q1 2015, an estimated $18.8M.
  • Amundi Asset Management US first reported a position in NPS PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Amundi Asset Management US's NPS PHARMACEUTICALS INC position peaked at $18.8M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held NPS PHARMACEUTICALS INC as of Q1 2015.

Based on Amundi Asset Management US's 13F filing for Q1 2015, filed 11 May 2015.